Global Rotavirus Infections Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Rotavirus Infections Drug

• 1.1 Definition of Rotavirus Infections Drug
• 1.2 Rotavirus Infections Drug Segment by Type
  • 1.2.1 Global Rotavirus Infections Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 RV-3BB
  • 1.2.3 RV-625
  • 1.2.4 UMN-2001
  • 1.2.5 Rotavac-5C
  • 1.2.6 Others
• 1.3 Rotavirus Infections Drug Segment by Applications
  • 1.3.1 Global Rotavirus Infections Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Rotavirus Infections Drug Overall Market
  • 1.4.1 Global Rotavirus Infections Drug Revenue (2014-2025)
  • 1.4.2 Global Rotavirus Infections Drug Production (2014-2025)
  • 1.4.3 North America Rotavirus Infections Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Rotavirus Infections Drug Status and Prospect (2014-2025)
  • 1.4.5 China Rotavirus Infections Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Rotavirus Infections Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Rotavirus Infections Drug Status and Prospect (2014-2025)
  • 1.4.8 India Rotavirus Infections Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Rotavirus Infections Drug
• 2.3 Manufacturing Process Analysis of Rotavirus Infections Drug
• 2.4 Industry Chain Structure of Rotavirus Infections Drug

3 Development and Manufacturing Plants Analysis of Rotavirus Infections Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Rotavirus Infections Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Rotavirus Infections Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Rotavirus Infections Drug Production and Capacity Analysis
• 4.2 Rotavirus Infections Drug Revenue Analysis
• 4.3 Rotavirus Infections Drug Price Analysis
• 4.4 Market Concentration Degree

5 Rotavirus Infections Drug Regional Market Analysis

• 5.1 Rotavirus Infections Drug Production by Regions
  • 5.1.1 Global Rotavirus Infections Drug Production by Regions
  • 5.1.2 Global Rotavirus Infections Drug Revenue by Regions
• 5.2 Rotavirus Infections Drug Consumption by Regions
• 5.3 North America Rotavirus Infections Drug Market Analysis
  • 5.3.1 North America Rotavirus Infections Drug Production
  • 5.3.2 North America Rotavirus Infections Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Rotavirus Infections Drug Import and Export
• 5.4 Europe Rotavirus Infections Drug Market Analysis
  • 5.4.1 Europe Rotavirus Infections Drug Production
  • 5.4.2 Europe Rotavirus Infections Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Rotavirus Infections Drug Import and Export
• 5.5 China Rotavirus Infections Drug Market Analysis
  • 5.5.1 China Rotavirus Infections Drug Production
  • 5.5.2 China Rotavirus Infections Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Rotavirus Infections Drug Import and Export
• 5.6 Japan Rotavirus Infections Drug Market Analysis
  • 5.6.1 Japan Rotavirus Infections Drug Production
  • 5.6.2 Japan Rotavirus Infections Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Rotavirus Infections Drug Import and Export
• 5.7 Southeast Asia Rotavirus Infections Drug Market Analysis
  • 5.7.1 Southeast Asia Rotavirus Infections Drug Production
  • 5.7.2 Southeast Asia Rotavirus Infections Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Rotavirus Infections Drug Import and Export
• 5.8 India Rotavirus Infections Drug Market Analysis
  • 5.8.1 India Rotavirus Infections Drug Production
  • 5.8.2 India Rotavirus Infections Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Rotavirus Infections Drug Import and Export

6 Rotavirus Infections Drug Segment Market Analysis (by Type)

• 6.1 Global Rotavirus Infections Drug Production by Type
• 6.2 Global Rotavirus Infections Drug Revenue by Type
• 6.3 Rotavirus Infections Drug Price by Type

7 Rotavirus Infections Drug Segment Market Analysis (by Application)

• 7.1 Global Rotavirus Infections Drug Consumption by Application
• 7.2 Global Rotavirus Infections Drug Consumption Market Share by Application (2014-2019)

8 Rotavirus Infections Drug Major Manufacturers Analysis

• 8.1 Beijing Minhai Biotechnology Co Ltd
  • 8.1.1 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Production Sites and Area Served
  • 8.1.2 Beijing Minhai Biotechnology Co Ltd Product Introduction, Application and Specification
  • 8.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bharat Biotech International Ltd
  • 8.2.1 Bharat Biotech International Ltd Rotavirus Infections Drug Production Sites and Area Served
  • 8.2.2 Bharat Biotech International Ltd Product Introduction, Application and Specification
  • 8.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Biological E Ltd
  • 8.3.1 Biological E Ltd Rotavirus Infections Drug Production Sites and Area Served
  • 8.3.2 Biological E Ltd Product Introduction, Application and Specification
  • 8.3.3 Biological E Ltd Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Curevac AG
  • 8.4.1 Curevac AG Rotavirus Infections Drug Production Sites and Area Served
  • 8.4.2 Curevac AG Product Introduction, Application and Specification
  • 8.4.3 Curevac AG Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Medicago Inc
  • 8.5.1 Medicago Inc Rotavirus Infections Drug Production Sites and Area Served
  • 8.5.2 Medicago Inc Product Introduction, Application and Specification
  • 8.5.3 Medicago Inc Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Nanotherapeutics Inc
  • 8.6.1 Nanotherapeutics Inc Rotavirus Infections Drug Production Sites and Area Served
  • 8.6.2 Nanotherapeutics Inc Product Introduction, Application and Specification
  • 8.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Serum Institute of India Ltd
  • 8.7.1 Serum Institute of India Ltd Rotavirus Infections Drug Production Sites and Area Served
  • 8.7.2 Serum Institute of India Ltd Product Introduction, Application and Specification
  • 8.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 UMN Pharma Inc
  • 8.8.1 UMN Pharma Inc Rotavirus Infections Drug Production Sites and Area Served
  • 8.8.2 UMN Pharma Inc Product Introduction, Application and Specification
  • 8.8.3 UMN Pharma Inc Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Wuhan Institute of Biological Products Co Ltd
  • 8.9.1 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Production Sites and Area Served
  • 8.9.2 Wuhan Institute of Biological Products Co Ltd Product Introduction, Application and Specification
  • 8.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Rotavirus Infections Drug Market

• 9.1 Global Rotavirus Infections Drug Market Trend Analysis
  • 9.1.1 Global Rotavirus Infections Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Rotavirus Infections Drug Regional Market Trend
  • 9.2.1 North America Rotavirus Infections Drug Forecast 2019-2025
  • 9.2.2 Europe Rotavirus Infections Drug Forecast 2019-2025
  • 9.2.3 China Rotavirus Infections Drug Forecast 2019-2025
  • 9.2.4 Japan Rotavirus Infections Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Rotavirus Infections Drug Forecast 2019-2025
  • 9.2.6 India Rotavirus Infections Drug Forecast 2019-2025
• 9.3 Rotavirus Infections Drug Market Trend (Product Type)
• 9.4 Rotavirus Infections Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Rotavirus Infections Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List